Skip to main content

Find Clinical Trials

Home
Conditions
Bioequivalence

Clinical trial condition

Bioequivalence

Explore clinical trials studying Bioequivalence. Study availability and eligibility vary by location and protocol.

140 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Bioequivalence trial results

Completed

A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy Volunteers

NCT03975166

Conditions: Bioequivalence
Locations: BECRO Clinical Facility Larissa, Thessaly, Greece

View Trial Details

Completed

The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.

NCT03951051

Conditions: Bioequivalence
Locations: Altasciences Company Inc. Mount Royal, Quebec, Canada

View Trial Details

Completed

Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

NCT03918551

Conditions: Bioequivalence
Locations: Altasciences Company Inc. Montreal, Quebec, Canada

View Trial Details

Completed

Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex

NCT04008979

Conditions: Bioequivalence
Locations: Not specified

View Trial Details

Completed

Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions

NCT03799536

Conditions: Bioequivalence
Locations: National Anti-Doping Laboratory Settl.Lesnoy, Minsk Oblast, Belarus

View Trial Details

Completed

Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

NCT03915340

Conditions: Bioequivalence
Locations: Altasciences Company Inc. Mount Royal, Quebec, Canada

View Trial Details

Completed

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade (BREATH-PK250-CC)

NCT03894280

Conditions: Bioequivalence
Locations: BECRO Clinical Facility Larissa, Thessaly, Greece

View Trial Details

Completed

A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers

NCT03860948

Conditions: Bioequivalence
Locations: Shanghai Xuhui District Central Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

NCT03702894

Conditions: Bioequivalence
Locations: State Autonomous Healthcare Facility of the Yaroslavl Region "Clinical Hospital No. 2" Yaroslavl, Yaroslavl Oblast, Russia

View Trial Details

Completed

Comparison of Two Formulations of Androxal

NCT01984398

Conditions: Bioequivalence
Locations: Clinical Pharmacology of miami Miami, Florida, United States

View Trial Details